CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 75 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $153 | – | 1,383 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 1,383 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 1,383 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $1,000 | 0.0% | 1,383 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 1,383 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $1,000 | -66.7% | 1,383 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $3,000 | 0.0% | 1,383 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $3,000 | +50.0% | 1,383 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $2,000 | – | 1,383 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
Aries Wealth Management | 27,900 | $160,000 | 0.10% |
Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |